Home > Back to Publisher > Report Information

U.S. Hepatitis Therapy Markets

Frost & Sullivan
September 1, 1999
SKU: MC1663

Abstract Table of Contents Related Reports

Countries covered: United States

With an overwhelming majority of hepatitis patients unresponsive to current treatments, participants in the hepatitis therapy markets are focusing their energies on R&D innovation. This report provides you with an overview of key technological developments in R&D and the benefits of an identified patient base. It includes coverage of major trends, revenue forecasts, product analysis, market share, market drivers and restraints, and more. Profiles of major industry participants are also included. From Frost & Sullivan.

Introducing the Market Engineering Consulting Report
- Introduction
- The Market Engineering System
- Market Engineering Report Elements
- Strategic Benefits of Market Engineering for Readers of This Report
- Top Ten Benefits of a Market Engineering Consulting Report
- A Word of Caution
Executive Summary
- Introduction to the U.S. Hepatitis Therapies Market
- Summary of Major Findings
Market Engineering Research Methodology
- Frost & Sullivan's 12-Step Market Engineering Research Methodology
- Frost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare Industry
- Pharmaceutical Forecast Model
- Presentation of Market Engineering Measurements, Definition and their Strategic Significance
- Glossary of Terms
Challenges in the Hepatitis Therapies Market
- Identification of Challenges Facing the Diagnostic Imaging Market
Market Engineering Research for the Hepatitis B Therapies Market
- Total Market Analysis
- Market Engineering Analysis for the Existing Hepatitis B Therapies Market
- Market Engineering Analysis of the Emerging Hepatitis B Therapies Market
Market Engineering Research for the Hepatitis C Therapies Market
- Total Market Analysis
- Market Engineering Analysis of the Existing Hepatitis C Therapies Market
- Market Engineering Analysis of the Emerging Hepatitis C Therapies Market
Overview of Hepatitis A, D, E, and G Therapies Market
- Market Overview and Definition
- Hepatitis A Therapies Market
- Hepatitis D Therapies Market
- Hepatitis E Therapies Market
- Hepatitis G Therapies Market
Market Engineering Strategy
- What Is Market Engineering Strategy?
- Market Engineering Strategic Recommendations
Market Engineering Planning
- Integrating Market Engineering into the Business Planning Process
Implementation of Market Engineering
- How to Implement Market Engineering in a Company
Market Engineering Monitoring of the Hepatitis Therapies Market
- The Purpose of Market Engineering Monitoring
- Frost & Sullivan's 1998 Market Engineering Award
- Frost & Sullivan's Strategic Recommendations for Further Research
Database of Key Industry Participants
- Market Participants
- Related Companies
- Associations

More United States Hepatitis Reports

The 2012 Hepatitis Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

U.S. Hepatitis C Market by Frost & Sullivan
This research service covers the U.S. hepatitis C (HCV) market from 2008 to 2016, with 2010 as the base year. Included are products on ...

Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers by Venture Planning Group
Rationale During the next ten years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including ...

Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to Follow by GlobalData
Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to Follow Summary Hepatitis C is caused by a type ...

Who's Doing What in Molecular Diagnostics ? - The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories by Kalorama Information
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

U.S. Hepatitis Therapy Markets

Share this report

Other tasks

Research Assistance

Related Markets

Free Alert Me service